Abstract

Surface-enhanced Raman scattering (SERS) has a broad application prospect in the field of tumor detection owing to its ultrahigh detective sensitivity. However, SERS analysis of serum remain a challenge in terms of repeatability and stability due to the maldistribution of the silver nanoparticles (Ag-NPs)-serum. With the aim to make up for this shortcoming, we report a new method for obtaining stable serum Raman signals utilizing the ordered arrays of pyramidal silicon (PSi) and Ag-NPs. We prove the practicability of this method by detecting the samples of serum from 50 lung cancer patients and 50 normal healthy people. Principal component analysis (PCA) of the serum SERS spectra shows that the spectral data of the two sample groups can form obvious and completely separated clusters. The receiver operating characteristic curve provides the sensitivity (100%) and specificity (90%) from the PCA-LDA method. This research indicates that a stable and label-free analysis technique of serum SERS based on Ag-NPs/PSi and PCA-LDA is promising for noninvasive lung cancer diagnoses.

Highlights

  • Despite the rapid development of medical science, the detection of lung cancer is still quite challenging

  • We proposed a novel strategy for serum surface-enhanced Raman scattering (SERS) analysis in lung cancer diagnosis by combining Ag-NPs with pyramidal silicon (PSi) as a substrate

  • The new method demonstrated that serum SERS based on Ag-NPs/PSi-substrates has an extensive prospect in the detection and analysis of tumor

Read more

Summary

Introduction

Despite the rapid development of medical science, the detection of lung cancer is still quite challenging. Many researchers have applied the SERS to perform label-free and non-invasive detection of serum including nasopharyngeal [13], colorectal [24], prostate [30], liver [31], and so forth Most of these studies used a common method that the serum was mixed with the noble-metal nanoparticles (NMNPs). This method accompanies problem of relatively poor stability due to the random distribution of NMNPs. In this paper, we proposed a novel strategy for serum SERS analysis in lung cancer diagnosis by combining Ag-NPs with pyramidal silicon (PSi) as a substrate. The new method demonstrated that serum SERS based on Ag-NPs/PSi-substrates has an extensive prospect in the detection and analysis of tumor

Subjects and protocol
SERS measurements
Results and discussion
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.